Identification of Cripto-1 in human milk Caterina BiancoChristian WechselbergerDavid S. Salomon OriginalPaper Pages: 1 - 7
The effect of tamoxifen on breast tumour vascularity L.P. MarsonK.M. KurianJ.M. Dixon OriginalPaper Pages: 9 - 15
Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer Henri MarretFranck PerrotinGilles Body OriginalPaper Pages: 17 - 23
The excess costs of breast cancer health care in Hispanic and non-Hispanic female members of a managed care organization Kristine TollestrupFloyd J. FrostHans V. Petersen OriginalPaper Pages: 25 - 31
Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer Emilio AlbaNuria RibellesJosé Miramón Conference Report Pages: 33 - 39
Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide Eric C. DietzeLisa YeeVictoria L. Seewaldt OriginalPaper Pages: 41 - 50
Data mining with decision trees for diagnosis of breast tumor in medical ultrasonic images Wen-Jia KuoRuey-Feng ChangCheng Chun Lee OriginalPaper Pages: 51 - 57
Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues A.L. SilvaJ. DiamondJ.L. Passos-Coelho OriginalPaper Pages: 59 - 66
Expression of glyoxalase I and II in normal and breast cancer tissues Antonio RulliLuciano CarliVincenzo Talesa OriginalPaper Pages: 67 - 72
Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments? Deborah FellowesLesley J FallowfieldJoan Houghton OriginalPaper Pages: 73 - 81
Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane C.H. SmorenburgM. BontenbalR. de Wit OriginalPaper Pages: 83 - 87